O'Day Daniel Patrick's Form 4 filing
Gilead Sciences, Inc. (GILD) · filed Sep 2, 2026
- Accession no.
- 0001638643-26-000031
- Filed
- Sep 2, 2026, 4:12 PM ET
- Trade date
- Sep 1, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.23M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| O'Day Daniel PatrickCIK 0001638643 | Director, Officer (Chairman & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | Common Stock | SSaleDisposed | −1,600 | $147.51 | −$236,013.92 | 590,533 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −7,992 | $148.36 | −$1,185,721.89 | 582,541 | Direct | |
| Sep 1, 2026 | Common Stock | SSaleDisposed | −5,408 | $149.38 | −$807,856.23 | 577,133 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.